zur Startseite
HomeHow to find usPrivacy PolicyImprint
Clinical Intergroup
Pathology Panel
Research
Clinical Trials
Members
News/Publications

iNNOVATE Follow-up data on efficacy and safety of ibrutinib in treatment naïve and relapsed patients with WM orally presented at this year’s ASH in San Diego

read more ›
 

IWWM10 - New York - 2018

We thank Steven Treon and his team for organizing the fantastic IWWM10 in New York in October this year. A great meeting and motivation for all of us to continue our efforts to improve treatment of WM
 
Show all news/publications ›

News/Publications

Presentations on WM at this year‘s ASH 2013 in New Orleans

from our consortium on:

 
  • Elevated Von Willebrand Factor Antigen Serum Levels and their association with poor prognosis In patients with symptomatic Waldenstrom’s Macroglobulinemia  (Efstathios Kastritis et al., Athens, Greece)
  • Disease unrelated mortality accounting for differences in survival in patients >75 Years with symptomatic Waldenström’s Macroglobulinemia  (Efstathios Kastritis et al., Athens, Greece)
  • Newest update of the WM2 trial on the efficacy of Bortezomib in patients with advanced Waldenström Macroglobulinemia  (V. Leblond et al., Paris, France)
 
‹ back